Patent · US Expired

Extracellular serine protease and a Bacillus subtilis alkaline neutral an serine protease mutant strain

US5585253A · kind A · utility

24Cited by
1References
33Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 27, 1989
Grant dateDec 17, 1996
Priority date
Expiry dateNov 27, 2009

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N15/75
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

A cloned gene (epr) encoding a novel extracellular protease, Epr, from Bacillus subtilis is described. Also described is a triple extracellular neutral, alkaline and serine protease deficient Bacillus subtilis mutant strain having deletions in the (npr), (apr) and (epr) genes encoding these proteases. The triple mutant strain was constructed by the gene conversion technique and produces about 1% of the extracellular proteolytic activity of the wild type. It is a particularly useful host for the production of heterologous proteins that are secreted into the growth medium.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.